novavax fda news - Search News

Novavax Gets FDA Approval To Resume Testing 2 Vaccines

Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold

The company explained that the U.S. Food and Drug Administration (FDA) removed its clinical hold on the studies, and will allow it "to begin enrolling the planned Phase 3 trial following the determination that Novavax satisfactorily addressed all clinical ...

KSL · 2d

FDA lifts clinical hold on Novavax's combo COVID-flu shot

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after identifying a safety concern.

biopharma-reporter · 2d

FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine

The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient.

Becker's Hospital Review2d

FDA lifts clinical hold on combined COVID-19-influenza vaccine trials

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical ...

Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...

Novavax sees weak Covid vaccine sales, convinced Sanofi can do better

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

2don MSN

Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter ...

Business Insider1d

Novavax price target lowered to $9 from $14 at TD Cowen

TD Cowen lowered the firm’s price target on Novavax (NVAX) to $9 from $14 and keeps a Hold rating on the shares. The firm said the FDA lifted its clinical hold on its COVID/flu combo and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results